The Endocannabinoid System, an Underexploited and Promising Niche for the Pharmacological Treatment of Obesity and Metabolic Diseases

Nutrients. 2022 Jan 18;14(3):421. doi: 10.3390/nu14030421.

Abstract

Obesity represents the most prevalent metabolic disease in the world at present, posing an important public health challenge [...].

Publication types

  • Editorial

MeSH terms

  • Endocannabinoids* / therapeutic use
  • Humans
  • Metabolic Diseases* / drug therapy
  • Obesity / drug therapy
  • Obesity / metabolism

Substances

  • Endocannabinoids